We are live on ! Find out more
ILI

INTERLEUKIN GENETICS INC
ILI

Delisted

ILI was delisted on the 13th of August, 2010.

Back to rankings

1 hedge funds and large institutions have $1K invested in INTERLEUKIN GENETICS INC in 2017 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

97% less capital invested

Capital invested by funds: $38K → $1K (-$37K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CL
CPWM LLC
Washington
-$3.04K

ILI Hedge Fund Activity: Q4 2017 in Review

1 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in INTERLEUKIN GENETICS INC (ILI) for Q4 2017, worth a combined $1K — down 97% from $38K a quarter earlier.

Fund positioning in ILI was balanced in Q4 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was CPWM LLC, cutting an estimated $3.04K.

  • 1 institutional investor held INTERLEUKIN GENETICS INC (ILI) as of Q4 2017, unchanged from Q3 2017.
  • Funds reported $1K of INTERLEUKIN GENETICS INC stock for Q4 2017, down 97% quarter-over-quarter.
  • 0 funds opened new INTERLEUKIN GENETICS INC positions in Q4 2017 and 0 closed out.
  • The largest INTERLEUKIN GENETICS INC seller in Q4 2017 was CPWM LLC, an estimated $3.04K sold.

Based on aggregated 13F filings for Q4 2017.